Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this
more true than in the elucidation and verification of the pathogenetic basis upon which they …

Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Of the myriad proteolytic enzymes implicated in the development of lung disease, neutrophil
elastase has undoubtedly some of the most versatile effects. Although its key physiologic …

Background— In ventricular dilatation or hypertrophy, an elevated end-diastolic pressure is
often assumed to be secondary to increased myocardial stiffness, but stiffness is rarely …

Background In fibrotic interstitial lung diseases, exertional breathlessness is strongly linked
to health-related quality of life (HRQOL). Breathlessness is often associated with oxygen …

1 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet 2020; 395: 497–506. 2 Yin Y, Wunderink RG. MERS, SARS …

Neutrophil elastase is a serine protease stored in the azurophilic granules of leukocytes. It
has been implicated in the pathology of several lung diseases and is generally presumed to …

Pleuroparenchymal fibroelastosis (PPFE) is an unusual pulmonary disease with unique
clinical, radiological, and pathological characteristics. Designated a rare idiopathic interstitial …

Rationale: Criteria for progressive pulmonary fibrosis (PPF) have been proposed, but their
prognostic value beyond categorical decline in FVC remains unclear. Objectives: To …

Background Proposed criteria for progressive fibrosing interstitial lung disease (PF-ILD) have
been linked to increased mortality risk, but lung function trajectory after satisfying individual …